Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Anna Stanhewicz, PhD
30 participants
Sep 11, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
12 weeks: 850mg metformin once daily for first 7 days then twice daily for the remaining 11 weeks.
12 weeks: placebo tablet once daily for the first 7 days then twice daily for the remaining 11 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05917587